FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved ...
Pharmaceutical Technology5h
FDA approves Vertex’s acute pain treatment Journavx
The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.
Vertex Stock Jumps After Non-Opioid Painkiller Gets FDA Approval
Shares of Vertex Pharmaceuticals rose 8% in off-hours trading after the pharmaceutical company won U.S. approval for the [first new non-opioid painkiller in decades]( ...
Vertex: Risky Valuation Amid Shaky Organic Growth
Vertex specializes in corporate tax compliance software, targeting a $22B global TAM with a focus on enterprise and SMB ...
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
unite14d
Sal Visca, Chief Technology Officer, Vertex
As Chief Technology Officer, Sal leads the company’s technology strategy, software engineering and innovation roadmap to ...
Vertex’s Latest Tax Rates and Rules Report Highlights a Surge in District Taxes
(NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today released the findings of their 2024 U.S. state and local End-of-Year Rates and Rules Report. It ...
Vertex Wireless Collaborates with Samsung and Pepperl+Fuchs for Intrinsically Safe Mobile Devices
This collaboration is set to revolutionize the industrial mobile communications landscape by introducing intrinsically safe ...
The Business Journals24d
Vertex turns to Watertown biotech for gene-editing medicines pact
Vertex Pharmaceuticals Inc. will work with ... Orna acquired Cambridge-based ReNAgade in 2024 to access the company’s technology for delivering RNA medicines. Orna had previously been focused ...
News Medical2d
VERTEX 80/80v FTIR Spectrometer from Bruker
The VERTEX 80/80v optics design allows PEAK flexibility and PEAK instrument performance at the same time. The unique Bruker Optics DigiTect ™ technology ensures PEAK signal-to-noise ratio ...